Discussing Dr Reddy‘s third quarter earnings, Sarabjit Kaur Nangra told CNBC-TV18‘s Ekta Batra and Sonia Shenoy the numbers were broadly in line but some aspects – decent margins despite higher R&D spend and a less-than-expected hit in revenues from Russia – were positive.
first published: Jan 29, 2015 02:59 pm
A collection of the most-viewed Moneycontrol videos.
Live: Will Nifty's downtrend continue to third session on expiry day? | Opening Bell
Nifty Slips Below 26,100 Amid Sluggish Trade, Midcaps Struggle; IT Lends Support | Closing Bell Live
Live: Can Nifty reach its all-time high levels this week? | Opening Bell
This Tenant says Andheri West is better than SOBO | The tenant
